• About
    • Login
    View Item 
    •   Institutional Repository Home
    • Electronic Theses and Dissertations
    • Electronic Theses and Dissertations
    • View Item
    •   Institutional Repository Home
    • Electronic Theses and Dissertations
    • Electronic Theses and Dissertations
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of Institutional RepositoryCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Sites of action and physiological impact of mGluR5 positive allosteric modulators

    Chen, Yelin
    : https://etd.library.vanderbilt.edu/etd-11072007-150603
    http://hdl.handle.net/1803/14449
    : 2007-12-28

    Abstract

    Positive allosteric modulators (PAMs) of metabotropic glutamate receptor subtype 5 (mGluR5) may provide a novel approach that could be useful in the treatment of certain central nervous system disorders. However, their physiological effects and pharmacological properties, such as sites of action, are not fully understood. It has been suggested that two distinct mGluR5 PAMs, CDPPB and CPPHA, might act by binding to two distinct allosteric sites. We synthesized a series of CDPPB analogs and reported that these compounds bind to an allosteric antagonist (MPEP) site with affinities that are closely related to their potencies as mGluR5 PAMs. Furthermore, their allosteric potentiation is antagonized by a neutral ligand at the MPEP site called 5MPEP and reduced by a mutation that eliminates MPEP binding. Additionally, we have also reported that CPPHA potentiates mGluR5 responses by a mechanism that is distinct from that of VU-29, a CDPPB analog. CPPHA-induced potentiation of mGluR5 responses is also blocked by 5MPEP. However, 5MPEP and MPEP inhibit CPPHA in a non competitive manner compared with its competitive inhibition of the effect of VU-29. Consistent with this, the mutation that eliminates the effect of VU-29 has no effect on the response to CPPHA. Conversely, a distinct mutation that eliminates the effect of CPPHA does not alter the response to VU-29. Together, these data suggest that CPPHA and VU-29 act at two distinct sites. mGluR5 has been implicated as playing an important role in hippocampal synaptic plasticity. However, the precise roles of mGluR5 in different forms of hippocampal synaptic plasticity remain unclear. We found VU-29 significantly enhanced threshold theta burst stimulation (TBS)-induced long-term potentiation (LTP), which was completely blocked by 5MPEP and was mimicked by a structurally distinct mGluR5-selective PAM. In addition, VU-29 potentiated LTP was blocked by the NMDA receptor antagonist or src kinase inhibitor, suggesting that it shares a common mechanism with suprathreshold TBS-induced LTP. These raise the possibility that mGluR5 PAMs could be used as potential cognition enhancing agents.
    Show full item record

    Files in this item

    Icon
    Name:
    thesis.pdf
    Size:
    2.342Mb
    Format:
    PDF
    View/Open

    This item appears in the following collection(s):

    • Electronic Theses and Dissertations

    Connect with Vanderbilt Libraries

    Your Vanderbilt

    • Alumni
    • Current Students
    • Faculty & Staff
    • International Students
    • Media
    • Parents & Family
    • Prospective Students
    • Researchers
    • Sports Fans
    • Visitors & Neighbors

    Support the Jean and Alexander Heard Libraries

    Support the Library...Give Now

    Gifts to the Libraries support the learning and research needs of the entire Vanderbilt community. Learn more about giving to the Libraries.

    Become a Friend of the Libraries

    Quick Links

    • Hours
    • About
    • Employment
    • Staff Directory
    • Accessibility Services
    • Contact
    • Vanderbilt Home
    • Privacy Policy